Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Obalon Therapeutics stock

Own Obalon Therapeutics stock in just a few minutes.

Obalon Therapeutics, Inc is a medical devices business based in the US. Obalon Therapeutics shares (OBLN) are listed on the NASDAQ and all prices are listed in US Dollars. Obalon Therapeutics employs 2 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Obalon Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OBLN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Obalon Therapeutics share price

Use our graph to track the performance of OBLN stocks over time.

Obalon Therapeutics shares at a glance

Information last updated 2021-04-23.
52-week range$0.66 - $7.57
50-day moving average $3.05
200-day moving average $2.39
Wall St. target price$6.15
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-13.27

Buy Obalon Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Obalon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Obalon Therapeutics financials

Revenue TTM $1.6 million
Gross profit TTM $531,000
Return on assets TTM -45.53%
Return on equity TTM -120.25%
Profit margin 0%
Book value $0.60
Market capitalisation $27.9 million

TTM: trailing 12 months

Shorting Obalon Therapeutics shares

There are currently 279,741 Obalon Therapeutics shares held short by investors – that's known as Obalon Therapeutics's "short interest". This figure is 11.6% down from 316,352 last month.

There are a few different ways that this level of interest in shorting Obalon Therapeutics shares can be evaluated.

Obalon Therapeutics's "short interest ratio" (SIR)

Obalon Therapeutics's "short interest ratio" (SIR) is the quantity of Obalon Therapeutics shares currently shorted divided by the average quantity of Obalon Therapeutics shares traded daily (recently around 1.1 million). Obalon Therapeutics's SIR currently stands at 0.26. In other words for every 100,000 Obalon Therapeutics shares traded daily on the market, roughly 260 shares are currently held short.

However Obalon Therapeutics's short interest can also be evaluated against the total number of Obalon Therapeutics shares, or, against the total number of tradable Obalon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Obalon Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Obalon Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0324% of the tradable shares (for every 100,000 tradable Obalon Therapeutics shares, roughly 32 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Obalon Therapeutics.

Find out more about how you can short Obalon Therapeutics stock.

Obalon Therapeutics share dividends

We're not expecting Obalon Therapeutics to pay a dividend over the next 12 months.

Have Obalon Therapeutics's shares ever split?

Obalon Therapeutics's shares were split on a 1:10 basis on 24 July 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Obalon Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Obalon Therapeutics shares which in turn could have impacted Obalon Therapeutics's share price.

Obalon Therapeutics share price volatility

Over the last 12 months, Obalon Therapeutics's shares have ranged in value from as little as $0.66 up to $7.57. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Obalon Therapeutics's is -1.2232. This would suggest that Obalon Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Obalon Therapeutics has bucked the trend.

Obalon Therapeutics overview

Obalon Therapeutics, Inc. , a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California. .

Frequently asked questions

What percentage of Obalon Therapeutics is owned by insiders or institutions?
Currently 3.229% of Obalon Therapeutics shares are held by insiders and 30.696% by institutions.
How many people work for Obalon Therapeutics?
Latest data suggests 2 work at Obalon Therapeutics.
When does the fiscal year end for Obalon Therapeutics?
Obalon Therapeutics's fiscal year ends in December.
Where is Obalon Therapeutics based?
Obalon Therapeutics's address is: 5421 Avenida Encinas, Carlsbad, CA, United States, 92008-4410
What is Obalon Therapeutics's ISIN number?
Obalon Therapeutics's international securities identification number is: US67424L2097
What is Obalon Therapeutics's CUSIP number?
Obalon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 67424L100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site